MedPath

Bupitroy Heavy

Brand Name: Bupitroy Heavy

Generic Name: Bupivacaine Hydrochloride

Active
Registration Number

DR-XY41274

Dosage Form

Solution for Spinal Injection

Issuance Date

August 5, 2022

Expiry Date

September 28, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength5mg/mL (0.5% w/v)
Packaging4 mL USP Type I, Clear and Colorless Glass Ampoule in Plastic Tray Box of 5's

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Anesthetic (Amide)
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Bupivacaine HydrochlorideActive
Monograph: Bupivacaine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform